CIBC Asset Management Inc boosted its stake in shares of CME Group Inc (NASDAQ:CME) by 10.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 37,911 shares of the financial services provider’s stock after buying an additional 3,668 shares during the period. CIBC Asset Management Inc’s holdings in CME Group were worth $6,239,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently bought and sold shares of CME. Acadian Asset Management LLC grew its stake in shares of CME Group by 591.0% in the 4th quarter. Acadian Asset Management LLC now owns 3,676 shares of the financial services provider’s stock valued at $691,000 after buying an additional 3,144 shares in the last quarter. Norges Bank bought a new stake in shares of CME Group in the 4th quarter valued at approximately $597,417,000. Thrivent Financial for Lutherans grew its stake in shares of CME Group by 8.2% in the 4th quarter. Thrivent Financial for Lutherans now owns 15,815 shares of the financial services provider’s stock valued at $2,975,000 after buying an additional 1,194 shares in the last quarter. First United Bank Trust grew its stake in shares of CME Group by 2.5% in the 1st quarter. First United Bank Trust now owns 7,725 shares of the financial services provider’s stock valued at $1,271,000 after buying an additional 185 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its stake in shares of CME Group by 49.7% in the 4th quarter. Public Employees Retirement System of Ohio now owns 335,039 shares of the financial services provider’s stock valued at $63,028,000 after buying an additional 111,297 shares in the last quarter. Hedge funds and other institutional investors own 84.78% of the company’s stock.
In other CME Group news, Director Jeffrey M. Bernacchi sold 10,087 shares of the company’s stock in a transaction that occurred on Tuesday, February 26th. The stock was sold at an average price of $177.94, for a total transaction of $1,794,880.78. Following the completion of the sale, the director now owns 42,004 shares of the company’s stock, valued at $7,474,191.76. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Charles P. Carey sold 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 8th. The stock was sold at an average price of $179.02, for a total value of $1,790,200.00. Following the sale, the director now directly owns 37,799 shares of the company’s stock, valued at approximately $6,766,776.98. The disclosure for this sale can be found here. Insiders have sold 38,489 shares of company stock valued at $6,739,196 in the last ninety days. Company insiders own 1.20% of the company’s stock.
Shares of CME Group stock opened at $183.29 on Thursday. The company has a market cap of $65.23 billion, a price-to-earnings ratio of 26.88, a P/E/G ratio of 4.17 and a beta of 0.32. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. CME Group Inc has a 12-month low of $157.21 and a 12-month high of $197.08.
CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, May 1st. The financial services provider reported $1.62 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.60 by $0.02. The firm had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.19 billion. CME Group had a return on equity of 9.29% and a net margin of 42.47%. The company’s revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.86 earnings per share. As a group, equities analysts predict that CME Group Inc will post 6.62 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 25th. Shareholders of record on Monday, June 10th will be given a dividend of $0.75 per share. The ex-dividend date is Friday, June 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.64%. CME Group’s payout ratio is currently 43.99%.
Several equities research analysts recently commented on CME shares. Bank of America set a $180.00 price target on CME Group and gave the company a “hold” rating in a research note on Tuesday, April 9th. ValuEngine raised CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a research note on Friday, February 15th. Zacks Investment Research cut CME Group from a “hold” rating to a “sell” rating in a research note on Tuesday, April 9th. Finally, BidaskClub cut CME Group from a “sell” rating to a “strong sell” rating in a research note on Friday, March 22nd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $189.71.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Story: Analyst Ratings Trading
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.